NCT07759076

Brief Summary

The goal of this study is to collect preliminary clinical performance data focused on the usability aspects of the human - machine interaction, with focus on planning, navigation and application of automated laser tattoo removal. The study will enroll adult patients with monochrome dark tattoos. In addition to the data collected on the human-machine interaction, it will also collect other outcomes like pain during treatment, overall user and patient satisfaction, and adverse events. For the participants, treatment will follow standard procedures. In addition to this, they will be followed up after 30 days, to see if any complications occured.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
3mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2026

Completed
6 months until next milestone

First Posted

Study publicly available on registry

August 11, 2026

Completed
21 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

August 11, 2026

Status Verified

August 1, 2026

Enrollment Period

3 months

First QC Date

February 10, 2026

Last Update Submit

August 10, 2026

Conditions

Keywords

Tattoo removalDermatologic laserPermanent Make-Up removalBenign epidermal pigment removalRobotNd:YAGAlexandrite

Outcome Measures

Primary Outcomes (4)

  • •VAS for defining target region, region of therapy, clarity and degree of completion of projection of region of therapy on patient skin

    Directly after treatment

  • •VAS for usefulness of indication of size of region of therapy

    Directly after treatment

  • • Y/N for laser path assessment

    Directly after treatment

  • • # for number of unintended interruptions

    Directly after treatment

Secondary Outcomes (6)

  • • Time required in minutes

    Directly after treatment

  • • VAS for assessing pain score

    Directly after treatment

  • • VAS for assessing ease of communication through user interface

    Directly after treatment

  • • VAS for assessing overall user and patient satisfaction

    Directly after treatment

  • • Collection of data on Adverse Events

    Up to 30 days after treatment

  • +1 more secondary outcomes

Study Arms (1)

Tattoo and Permanent Make-Up Removal

EXPERIMENTAL
Device: PiRAT 1.0, tattoo removal laser

Interventions

The investigational device, PiRAT, uses a standard laser, but with added automation which has the potential to perform the procedure more quickly and precisely, with less heat accumulation and less documentation required. observed, documented, and assessed in real-life circumstances.Documentation of patient / skin data

Tattoo and Permanent Make-Up Removal

Eligibility Criteria

Age18 Years - 84 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (18 - 84 years)
  • Woman or man (for women in their reproductive age, a confirmation of a pregnancy test with negative result is mandatory)
  • Fitzpatrick skin types I-VI
  • Monochrome dark tattoo (black, dark grey, dark blue, dark green, dark red, puce)
  • Tattoo size ≤ A5 (311 cm2)

You may not qualify if:

  • Patients with absolute or relative contraindications (according to IFU)
  • Pregnancy or breastfeeding
  • History of keloids or hypertrophic scarring
  • Active skin infections or conditions at the tattoo site
  • Use of photosensitizing medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Re.Naissance

Basel, Canton of Basel-City, 4056, Switzerland

Location

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2026

First Posted

August 11, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

August 11, 2026

Record last verified: 2026-08

Locations